News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current MACK market cap is 213.68M. The company's latest EPS is USD -0.0814 and P/E is -180.84.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 139k | 0 | 0 |
| Operating Income | -504k | -607k | -447k | -569k | -531k |
| Net Income | -442k | -492k | -271k | -391k | -279k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.27M | -5.01M | -2.62M | -2.17M | -2.18M |
| Net Income | -17.33M | -3.03M | -2.46M | -1.54M | -1.18M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.64M | 19.84M | 19.64M | 19.45M | 19.3M |
| Total Liabilities | 448k | 589k | 463k | 411k | 493k |
| Total Equity | 13.19M | 19.25M | 19.17M | 19.04M | 18.81M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.08M | 16.78M | 14.75M | 19.84M | 19.19M |
| Total Liabilities | 2.77M | 770k | 562k | 589k | 441k |
| Total Equity | 17.31M | 16.01M | 14.19M | 19.25M | 18.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.56M | -1.74M | -356k | -1.02M | -1.23M |
| Investing | 445k | 445k | 139k | -8.67M | -12.52M |
| Financing | N/A | 6.53M | 179k | 388k | 388k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.37M | -4.63M | -218k | -1.74M | -1.52M |
| Investing | 69.83M | 2.14M | 144k | 445k | -12.45M |
| Financing | -42.54M | -56k | 239k | 6.53M | 521k |
| Market Cap | 213.68M |
| Price to Earnings Ratio | -180.84 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 35.68 |
| Price to Book Ratio | 11.4 |
| Dividend Yield | - |
| Shares Outstanding | 14.52M |
| Average Volume (1 week) | 112.92k |
| Average Volume (1 Month) | 124.77k |
| 52 Week Change | 17.48% |
| 52 Week High | 15.89 |
| 52 Week Low | 11.53 |
| Spread (Intraday) | 0.06 (0.41%) |
| Company Name | Merrimack Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.merrimack.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
